Alkermes Plc is a biopharmaceutical company focused on developing innovative treatments for people suffering from neurological and psychiatric disorders, as well as addiction
The company leverages its proprietary technologies and drug delivery systems to create medicines that address complex medical needs. With a commitment to advancing science and improving patient outcomes, Alkermes engages in the research, development, and commercialization of therapies that aim to enhance the quality of life for individuals dealing with serious health challenges.
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.
